Litigation Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-04-25 |
| Court | District Court, D. Delaware | Date Terminated | 2020-06-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 6,936,612; 7,208,489; 7,456,168 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-04-25 | 1 | Complaint | of U.S. Patent No. 6,936,612 (“the ’612 patent”); U.S. Patent No. 7,208,489 (“the ’489 patent”); and …“the ’168 patent”). These three patents are referred to collectively herein as “the patents-in- suit.…’612 patent, and/or the validity of the ’612 patent. 47. Claim 1 of the ’612 patent recites…claims of the ’489 patent, including claim 1–7 and 9 of the ’489 patent, and the ’489 patent has been listed…claims of the ’168 patent, including claim 1 of the ’168 patent, and the ’168 patent has been listed in | External link to document |
| 2019-07-15 | 11 | Answer to Complaint | be an action for patent infringement of U.S. Patent Nos. 6,936,612 (“the ‘612 patent”); 7,208,489 (“the…“the ‘489 patent”); 7,456,168 (“the ‘168 patent”) (collectively, “the patents-in-suit”) under the patent…‘168 patents are invalid for failure to satisfy one or more of the conditions for patentability under…Teva USA admits that it has previously engaged in patent litigation rising from the process contemplated… COUNT I-INFRINGEMENT OF THE ‘612 PATENT 23. Teva incorporates by reference | External link to document |
| 2019-04-25 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,936,612 B2; 7,208,489 B2; and… 2019 1 June 2020 1:19-cv-00759 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
